Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CSX Corp
CSX
$95.6B
| $9.52M | 0.25% |
+327,752
| New | +$10.7M |
|
52
Arrow Electronics
ARW
$10.7B
| $9.45M | 0.25% |
84,321
+65,737
| +354% | +$7.67M |
|
53
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $9.44M | 0.25% |
+300,000
| New | +$10.4M |
|
|
ZEN
54
DELISTED
ZENDESK INC
ZEN
| $9.42M | 0.25% |
127,230
+123,703
| +3,507% | +$12.2M |
|
55
New York Times
NYT
$10.6B
| $9.3M | 0.24% |
333,488
+199,247
| +148% | +$7.2M |
|
|
CFLT
56
DELISTED
Confluent
CFLT
| $9.3M | 0.24% |
400,000
-14,252
| -3% | -$384K |
|
57
Federal Realty Investment Trust
FRT
$10.1B
| $9.05M | 0.24% |
94,575
-707
| -0.7% | -$79.4K |
|
58
Otis Worldwide
OTIS
$27.2B
| $9.01M | 0.24% |
127,499
| – | – |
|
59
Crown Castle
CCI
$32.1B
| $8.76M | 0.23% |
52,023
+37,616
| +261% | +$6.84M |
|
|
ANSS
60
DELISTED
Ansys
ANSS
| $8.74M | 0.23% |
36,528
+23,249
| +175% | +$6.15M |
|
61
Rollins
ROL
$17.8B
| $8.6M | 0.23% |
+246,173
| New | +$8.45M |
|
62
Twilio
TWLO
$34.6B
| $8.52M | 0.22% |
101,658
+41,274
| +68% | +$4.62M |
|
63
TransDigm Group
TDG
$66.4B
| $8.51M | 0.22% |
15,852
+2,262
| +17% | +$1.34M |
|
64
Moody's
MCO
$87.2B
| $8.48M | 0.22% |
31,187
+7,520
| +32% | +$2.25M |
|
65
Fortune Brands Innovations
FBIN
$5.32B
| $8.48M | 0.22% |
165,610
+6,464
| +4% | +$379K |
|
66
Teva Pharmaceuticals
TEVA
$43.5B
| $8.38M | 0.22% |
1,115,087
+415,000
| +59% | +$3.62M |
|
67
Wyndham Hotels & Resorts
WH
$5.54B
| $8.27M | 0.22% |
125,863
+47,479
| +61% | +$3.74M |
|
68
Hasbro
HAS
$13.2B
| $8.26M | 0.22% |
100,835
-124,297
| -55% | -$10.8M |
|
69
Marathon Petroleum
MPC
$101B
| $8.21M | 0.22% |
99,914
+69,186
| +225% | +$6.47M |
|
70
Rockwell Automation
ROK
$48.5B
| $8.11M | 0.21% |
40,691
+31,208
| +329% | +$7.05M |
|
|
71
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $8.02M | 0.21% |
+200,000
| New | +$8.39M |
|
72
Intuit
INTU
$100B
| $7.9M | 0.21% |
20,498
+5,542
| +37% | +$2.29M |
|
73
Expedia Group
EXPE
$38.6B
| $7.88M | 0.21% |
83,130
+22,307
| +37% | +$3.16M |
|
74
Southern Company
SO
$102B
| $7.83M | 0.21% |
109,869
+19,684
| +22% | +$1.45M |
|
75
Toyota
TM
$234B
| $7.8M | 0.2% |
+50,600
| New | +$8.36M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.